Gene: ZNF300
Official Full Name: zinc finger protein 300provided by HGNC
Gene Summary: The protein encoded by this gene is a C2H2-type zinc finger DNA binding protein and likely transcriptional regulator. The function of this protein is not yet known. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23320 | ZNF300 Knockout cell line (HeLa) | Human | ZNF300 | 1:3~1:6 | Negative | Online Inquiry |
KO23321 | ZNF300 Knockout cell line (HEK293) | Human | ZNF300 | 1:3~1:6 | Negative | Online Inquiry |
KO23322 | ZNF300 Knockout cell line (A549) | Human | ZNF300 | 1:3~1:4 | Negative | Online Inquiry |
ZNF300 Gene Knockout Cell Lines are specifically engineered cellular models designed to facilitate the study of the ZNF300 gene, which encodes a zinc finger protein involved in various biological processes, including transcription regulation and cell growth. By utilizing CRISPR/Cas9 gene-editing technology, these cell lines have been constructed to have a complete disruption of ZNF300 function, allowing researchers to explore the gene's role in disease mechanisms and cellular functions without the interference of its normal expression.
The key function of the ZNF300 Gene Knockout Cell Lines lies in their ability to provide insights into the biological pathways influenced by the ZNF300 gene. Upon knockout, researchers can observe cellular behavior changes, alterations in gene expression profiles, and differences in response to various stimuli or drug candidates. This model is particularly valuable in investigating tumorigenesis, stem cell differentiation, and the molecular basis of specific genetic disorders.
The scientific importance of ZNF300 knockout models extends into both foundational research and clinical applications, offering potential pathways for novel therapeutic strategies. By understanding how the absence of ZNF300 impacts cellular processes, researchers can identify new biomarkers for disease progression and therapeutic targets.
What sets ZNF300 Gene Knockout Cell Lines apart from traditional knockout models is their high efficiency and specificity in gene editing, as well as reduced off-target effects, all of which enhance data reliability. Furthermore, these cell lines are readily available and compatible with various high-throughput screening applications, making them convenient for extensive experimental protocols.
This product holds immense value for researchers and clinicians seeking to elucidate the functional roles of the ZNF300 gene. It empowers them to leverage advanced gene-editing techniques to advance their studies, driving innovation in both academia and the biopharmaceutical industry.
With years of experience in the field, our company specializes in providing top-tier biological products, ensuring that researchers receive reliable, validated tools to accelerate their discoveries while adhering to the highest standards of quality and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.